AAPL   322.31 (+1.37%)
MSFT   182.59 (-0.36%)
FB   229.71 (+2.05%)
GOOGL   1,431.97 (-0.11%)
AMZN   2,467.55 (+1.03%)
NVDA   351.12 (-1.10%)
CGC   16.62 (-4.32%)
BABA   206.47 (-0.44%)
MU   46.51 (-2.92%)
GE   6.69 (+1.67%)
TSLA   887.88 (+6.33%)
T   31.00 (+0.45%)
F   5.83 (+2.10%)
GILD   75.66 (-2.79%)
DIS   119.14 (+1.57%)
NFLX   424.62 (+1.17%)
BA   151.28 (+3.72%)
AAPL   322.31 (+1.37%)
MSFT   182.59 (-0.36%)
FB   229.71 (+2.05%)
GOOGL   1,431.97 (-0.11%)
AMZN   2,467.55 (+1.03%)
NVDA   351.12 (-1.10%)
CGC   16.62 (-4.32%)
BABA   206.47 (-0.44%)
MU   46.51 (-2.92%)
GE   6.69 (+1.67%)
TSLA   887.88 (+6.33%)
T   31.00 (+0.45%)
F   5.83 (+2.10%)
GILD   75.66 (-2.79%)
DIS   119.14 (+1.57%)
NFLX   424.62 (+1.17%)
BA   151.28 (+3.72%)
AAPL   322.31 (+1.37%)
MSFT   182.59 (-0.36%)
FB   229.71 (+2.05%)
GOOGL   1,431.97 (-0.11%)
AMZN   2,467.55 (+1.03%)
NVDA   351.12 (-1.10%)
CGC   16.62 (-4.32%)
BABA   206.47 (-0.44%)
MU   46.51 (-2.92%)
GE   6.69 (+1.67%)
TSLA   887.88 (+6.33%)
T   31.00 (+0.45%)
F   5.83 (+2.10%)
GILD   75.66 (-2.79%)
DIS   119.14 (+1.57%)
NFLX   424.62 (+1.17%)
BA   151.28 (+3.72%)
AAPL   322.31 (+1.37%)
MSFT   182.59 (-0.36%)
FB   229.71 (+2.05%)
GOOGL   1,431.97 (-0.11%)
AMZN   2,467.55 (+1.03%)
NVDA   351.12 (-1.10%)
CGC   16.62 (-4.32%)
BABA   206.47 (-0.44%)
MU   46.51 (-2.92%)
GE   6.69 (+1.67%)
TSLA   887.88 (+6.33%)
T   31.00 (+0.45%)
F   5.83 (+2.10%)
GILD   75.66 (-2.79%)
DIS   119.14 (+1.57%)
NFLX   424.62 (+1.17%)
BA   151.28 (+3.72%)
Log in

NASDAQ:MNTAMomenta Pharmaceuticals SEC Filings & 10K Form

$31.36
-0.12 (-0.38 %)
(As of 06/1/2020 03:06 PM ET)
Add
Compare
Today's Range
$30.78
Now: $31.36
$31.78
50-Day Range
$26.61
MA: $31.17
$34.30
52-Week Range
$9.51
Now: $31.36
$35.13
Volume20,531 shs
Average Volume945,211 shs
Market Capitalization$3.69 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.47

SEC Filings

Momenta Pharmaceuticals (NASDAQ:MNTA) SEC Filings

DateFilerForm TypeView
05/21/2020
4:06 PM
FIER IAN (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2020
3:34 PM
BELTRAMELLO JO ANN (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2020
5:04 PM
Momenta Pharmaceuticals (Issuer)
WHEELER CRAIG A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/12/2020
3:49 PM
Manning Anthony M. (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/12/2020
3:47 PM
BELTRAMELLO JO ANN (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/11/2020
3:24 PM
Momenta Pharmaceuticals (Issuer)
WHEELER CRAIG A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/11/2020
3:23 PM
FIER IAN (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/11/2020
3:22 PM
Manning Anthony M. (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/11/2020
3:20 PM
KWON YOUNG (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2020
3:33 PM
Momenta Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/07/2020
7:11 AM
Momenta Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/06/2020
8:59 AM
Momenta Pharmaceuticals (Filer)
Form CT ORDER
05/06/2020
8:59 AM
Momenta Pharmaceuticals (Filer)
Form CT ORDER
04/28/2020
4:24 PM
BELTRAMELLO JO ANN (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/24/2020
4:28 PM
Momenta Pharmaceuticals (Filer)
Form DEF 14A
04/22/2020
3:08 PM
Manning Anthony M. (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/21/2020
3:22 PM
Arroyo Santiago (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/21/2020
3:21 PM
BELTRAMELLO JO ANN (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/21/2020
3:21 PM
Carvajal Alejandra (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/21/2020
3:21 PM
FIER IAN (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/21/2020
3:20 PM
KWON YOUNG (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/21/2020
3:19 PM
Manning Anthony M. (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/17/2020
3:15 PM
BELTRAMELLO JO ANN (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/14/2020
5:07 PM
Cieplinska Agnieszka (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/10/2020
7:00 AM
Momenta Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/02/2020
6:40 AM
Momenta Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/09/2020
4:27 PM
Momenta Pharmaceuticals (Issuer)
WHEELER CRAIG A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/09/2020
4:17 PM
KWON YOUNG (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/09/2020
4:16 PM
BELTRAMELLO JO ANN (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/09/2020
4:15 PM
Manning Anthony M. (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/09/2020
4:14 PM
Carvajal Alejandra (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/09/2020
4:12 PM
Arroyo Santiago (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2020
6:30 AM
Momenta Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/24/2020
6:26 PM
FIER IAN (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2020
5:43 PM
Carvajal Alejandra (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2020
5:42 PM
Momenta Pharmaceuticals (Issuer)
WHEELER CRAIG A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2020
5:55 PM
Arroyo Santiago (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2020
5:55 PM
BELTRAMELLO JO ANN (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2020
5:54 PM
KWON YOUNG (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2020
5:54 PM
Manning Anthony M. (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2020
5:53 PM
FIER IAN (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2020
5:53 PM
Momenta Pharmaceuticals (Issuer)
WHEELER CRAIG A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2020
5:52 PM
Carvajal Alejandra (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2020
5:00 PM
Momenta Pharmaceuticals (Issuer)
WHEELER CRAIG A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2020
4:29 PM
BELTRAMELLO JO ANN (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2020
4:28 PM
Manning Anthony M. (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2020
4:28 PM
FIER IAN (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2020
4:27 PM
KWON YOUNG (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2020
6:05 PM
Arroyo Santiago (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2020
6:04 PM
Carvajal Alejandra (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2020
6:04 PM
FIER IAN (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2020
6:03 PM
BELTRAMELLO JO ANN (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2020
6:03 PM
Momenta Pharmaceuticals (Issuer)
WHEELER CRAIG A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2020
6:02 PM
KWON YOUNG (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2020
6:01 PM
Manning Anthony M. (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2020
6:00 PM
Cieplinska Agnieszka (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2020
4:19 PM
Momenta Pharmaceuticals (Issuer)
WHEELER CRAIG A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2020
4:19 PM
Momenta Pharmaceuticals (Issuer)
WHEELER CRAIG A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/28/2020
11:05 AM
Momenta Pharmaceuticals (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
01/27/2020
4:49 PM
BELTRAMELLO JO ANN (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2020
3:41 PM
Carvajal Alejandra (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2020
3:41 PM
FIER IAN (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2020
3:40 PM
Manning Anthony M. (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2020
4:14 PM
Gutierrez-Ramos Jose-Carlos (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2020
4:18 PM
FIER IAN (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2020
4:17 PM
Manning Anthony M. (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2020
4:16 PM
Carvajal Alejandra (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2020
4:15 PM
BELTRAMELLO JO ANN (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2020
4:15 PM
Arroyo Santiago (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2020
4:13 PM
KWON YOUNG (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2020
3:15 PM
BELTRAMELLO JO ANN (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2020
3:14 PM
Manning Anthony M. (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/16/2020
4:14 PM
BELTRAMELLO JO ANN (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/16/2020
4:14 PM
FIER IAN (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/16/2020
4:13 PM
Momenta Pharmaceuticals (Issuer)
Stoner Elizabeth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/15/2020
3:20 PM
Cieplinska Agnieszka (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/13/2020
6:31 AM
Momenta Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/03/2020
7:00 AM
Momenta Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/27/2019
4:00 PM
FIER IAN (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/27/2019
3:59 PM
Manning Anthony M. (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/27/2019
3:57 PM
BELTRAMELLO JO ANN (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2019
3:18 PM
Barlow Jane F (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2019
3:17 PM
Barlow Jane F (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
12/13/2019
3:17 PM
Momenta Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/12/2019
4:28 PM
Momenta Pharmaceuticals (Filer)
Form 424B5
12/12/2019
4:26 PM
Momenta Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/10/2019
4:27 PM
Momenta Pharmaceuticals (Filer)
Form 424B5
12/10/2019
3:11 PM
Momenta Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/10/2019
3:01 PM
Momenta Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/03/2019
5:11 PM
Momenta Pharmaceuticals (Issuer)
WHEELER CRAIG A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2019
7:41 PM
Momenta Pharmaceuticals (Issuer)
WHEELER CRAIG A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/15/2019
7:00 AM
Momenta Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2019
5:11 PM
Manning Anthony M. (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2019
5:10 PM
Momenta Pharmaceuticals (Issuer)
WHEELER CRAIG A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2019
4:14 PM
Momenta Pharmaceuticals (Issuer)
WHEELER CRAIG A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2019
4:13 PM
FIER IAN (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2019
4:12 PM
KWON YOUNG (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2019
4:11 PM
Manning Anthony M. (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2019
4:10 PM
BELTRAMELLO JO ANN (Reporting)
Momenta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2019
3:19 PM
Momenta Pharmaceuticals (Issuer)
WHEELER CRAIG A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 6/1/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.